Download PDF - Robson Hall Faculty of Law
Download PDF - Robson Hall Faculty of Law Download PDF - Robson Hall Faculty of Law
148 MANITOBA LAW JOURNAL |VOLUME 35 NUMBER 1 defence, as set out in the Code, if he was to commit a crime in that condition. ii) The person afflicted is aware of his condition and has been successfully medicated such that adhering to the medication schedule as prescribed will put him into a “stable phase”. 16 The stable phase renders him lucid and competent so as to negate the relevant effects of the disease of the mind and able to appreciate the nature and quality of his acts and know when they are wrong. He would, therefore, not have the NCR defence available to him if he were to commit a crime at this stage. This point is critical because if the person, despite proper adherence to medication, was still left with significant aspects of the “diseased mind” such that he never ceased to be NCR, then any exacerbation of his condition can still be attributed to the condition itself, and thus all of his actions would remain under the protection of the NCR defence. iii) While the person is lucid and competent in his stable state, he fails to take his medication, which he knows, either from experience or from being told by a health care professional, is likely to result in a worsening of his mental condition. Specifically, he must know that he may lose the ability to tell right from wrong, that he may suffer from serious hallucinations, lose touch with reality, etc. iv) Subsequently, as a result of discontinuing the medication, he returns to a disordered state such that he again has a disease of the mind and would again potentially qualify for the NCR defence. v) The person commits a crime at this stage while he has a disease of the mind and cannot appreciate the nature or quality of the act nor does he know the act is wrong. It would be useful at this stage to outline the standard treatment process which a mentally disordered person might face. This information pertains specifically to people with schizophrenia, as this paper deals primarily with cases concerning that mental disorder. Other mental disorders with similar symptomologies and treatment structures would fall under the proposal of this paper as well. First, there is the “acute phase”, wherein psychotic symptoms begin to manifest themselves. Patients may seek treatment at this point and emphasis is 16 Pharmacotherapy, “Clinical Practice Guidelines for Treatment of Schizophrenia” (2005) 50:S1 Can J Psychiatry, 19S at 20S. Schizophrenia is broken down into three stages: acute, stabilizing, and stable. At the stable phase, the person is as stable as their medication can make them. Although the term applies to schizophrenia somewhat uniquely, for convenience, I will use the term “stable phase” to denote all analogous periods in other mental disorders, wherein the person is similarly and effectively medicated so as to leave them legally competent.
A Tough Pill to Swallow 149 placed on evaluating them in terms of the level of danger which they pose. 17 The next stage is the stabilization phase, in which the person is medicated to reduce their positive psychotic symptoms. Adherence to medication is critical at this stage. 18 Finally, there is the stable phase, which is the focus of this paper. Relapse prevention is an important goal during this phase. 19 Individual response to medication is highly variable, but the use of antipsychotic medications is an essential part of a treatment plan. 20 While undergoing treatment, patients are typically provided with information concerning the nature of their disorder, as well as the risks and benefits of treatment so that they may play an informed and participatory role in their treatment. 21 This means that the theoretical patient I refer to in this paper can reasonably be assumed to have been informed of the dangerous consequences which would accompany failing to adhere to his medication. If a patient had not been so informed and remained ignorant of the gravity of his mental illness and the importance of medication, he obviously should not be faulted if he fails to adhere to it. While the patient still has the right to determine his own course of treatment or refuse it altogether, 22 this right is not absolute. In cases where the patient is not competent to make decisions the decision may be made for him. A determination of incompetence would involve consideration of whether he is mentally impaired to the extent that he does not understand the nature of his condition or the consequences of obtaining or not obtaining treatment. 23 For the purposes of this paper, I assume that the person in question is competent to make treatment choices. Nevertheless, just because the patient has the right to choose to abstain from medication, does not mean that he should be able to do so with impunity. To the extent that exercising a right entails a foreseeable risk of harm to others, I think it is plain that a person ought to be held accountable for exercising that right. As the issue of culpability in an avoidable mentally disordered state is analyzed, it may be helpful to keep in mind a specific scenario. Imagine a person who has schizophrenia, paranoid type, or a person with a condition similar to that of Li or Joubert. As with Joubert (but unlike Li), this person has been diagnosed by his doctor who has prescribed an anti-psychotic medication to be taken regularly. The medication is effective and alleviates most symptoms of the disorder, leaving him in a mentally stable phase. The medication produces some 17 18 19 20 21 22 23 Ibid at 20S. Ibid. Ibid at 22S. Ibid at 19S. Ibid. See The Mental Health Act , CCSM c M110 s 26. Ibid at s 27(2).
- Page 107 and 108: Gladue: Beyond Myth 97 ... The resu
- Page 109 and 110: Gladue: Beyond Myth 99 that an Indi
- Page 111 and 112: Gladue: Beyond Myth 101 judge to or
- Page 113 and 114: Gladue: Beyond Myth 103 happens a f
- Page 115 and 116: Gladue: Beyond Myth 105 The myth of
- Page 117 and 118: Gladue: Beyond Myth 107 The reality
- Page 119 and 120: Gladue: Beyond Myth 109 than inspir
- Page 121 and 122: The National Academy of Sciences, C
- Page 123 and 124: Canadian DNA Jurisprudence and Chan
- Page 125 and 126: Canadian DNA Jurisprudence and Chan
- Page 127 and 128: Canadian DNA Jurisprudence and Chan
- Page 129 and 130: Canadian DNA Jurisprudence and Chan
- Page 131 and 132: Canadian DNA Jurisprudence and Chan
- Page 133 and 134: Canadian DNA Jurisprudence and Chan
- Page 135 and 136: Canadian DNA Jurisprudence and Chan
- Page 137 and 138: Canadian DNA Jurisprudence and Chan
- Page 139 and 140: Canadian DNA Jurisprudence and Chan
- Page 141 and 142: Canadian DNA Jurisprudence and Chan
- Page 143 and 144: Canadian DNA Jurisprudence and Chan
- Page 145 and 146: Canadian DNA Jurisprudence and Chan
- Page 147 and 148: Canadian DNA Jurisprudence and Chan
- Page 149 and 150: Canadian DNA Jurisprudence and Chan
- Page 151 and 152: Canadian DNA Jurisprudence and Chan
- Page 153 and 154: A Tough Pill to Swallow: Criminal C
- Page 155 and 156: A Tough Pill to Swallow 145 really
- Page 157: A Tough Pill to Swallow 147 II. WHA
- Page 161 and 162: A Tough Pill to Swallow 151 respond
- Page 163 and 164: A Tough Pill to Swallow 153 foresee
- Page 165 and 166: A Tough Pill to Swallow 155 remedia
- Page 167 and 168: A Tough Pill to Swallow 157 and bur
- Page 169 and 170: A Tough Pill to Swallow 159 was mos
- Page 171 and 172: A Tough Pill to Swallow 161 argued
- Page 173 and 174: A Tough Pill to Swallow 163 not a m
- Page 175 and 176: A Tough Pill to Swallow 165 Despite
- Page 177 and 178: A Tough Pill to Swallow 167 adverte
- Page 179 and 180: A Tough Pill to Swallow 169 to be o
- Page 181 and 182: A Tough Pill to Swallow 171 1. Comm
- Page 183 and 184: A Tough Pill to Swallow 173 down hi
- Page 185 and 186: A Tough Pill to Swallow 175 about a
- Page 187 and 188: A Tough Pill to Swallow 177 logisti
- Page 189 and 190: A Tough Pill to Swallow 179 when it
- Page 191 and 192: Legal Research in Canada’s Provin
- Page 193 and 194: Legal Research in Canada’s Provin
- Page 195 and 196: Legal Research in Canada’s Provin
- Page 197 and 198: Legal Research in Canada’s Provin
- Page 199 and 200: Legal Research in Canada’s Provin
- Page 201 and 202: Legal Research in Canada’s Provin
- Page 203 and 204: Legal Research in Canada’s Provin
- Page 205 and 206: Legal Research in Canada’s Provin
- Page 207 and 208: Legal Research in Canada’s Provin
A Tough Pill to Swallow 149<br />
placed on evaluating them in terms <strong>of</strong> the level <strong>of</strong> danger which they pose. 17 The<br />
next stage is the stabilization phase, in which the person is medicated to reduce<br />
their positive psychotic symptoms. Adherence to medication is critical at this<br />
stage. 18 Finally, there is the stable phase, which is the focus <strong>of</strong> this paper. Relapse<br />
prevention is an important goal during this phase. 19<br />
Individual response to medication is highly variable, but the use <strong>of</strong><br />
antipsychotic medications is an essential part <strong>of</strong> a treatment plan. 20 While<br />
undergoing treatment, patients are typically provided with information<br />
concerning the nature <strong>of</strong> their disorder, as well as the risks and benefits <strong>of</strong><br />
treatment so that they may play an informed and participatory role in their<br />
treatment. 21 This means that the theoretical patient I refer to in this paper can<br />
reasonably be assumed to have been informed <strong>of</strong> the dangerous consequences<br />
which would accompany failing to adhere to his medication. If a patient had not<br />
been so informed and remained ignorant <strong>of</strong> the gravity <strong>of</strong> his mental illness and<br />
the importance <strong>of</strong> medication, he obviously should not be faulted if he fails to<br />
adhere to it.<br />
While the patient still has the right to determine his own course <strong>of</strong><br />
treatment or refuse it altogether, 22 this right is not absolute. In cases where the<br />
patient is not competent to make decisions the decision may be made for him. A<br />
determination <strong>of</strong> incompetence would involve consideration <strong>of</strong> whether he is<br />
mentally impaired to the extent that he does not understand the nature <strong>of</strong> his<br />
condition or the consequences <strong>of</strong> obtaining or not obtaining treatment. 23 For the<br />
purposes <strong>of</strong> this paper, I assume that the person in question is competent to make<br />
treatment choices.<br />
Nevertheless, just because the patient has the right to choose to abstain from<br />
medication, does not mean that he should be able to do so with impunity. To the<br />
extent that exercising a right entails a foreseeable risk <strong>of</strong> harm to others, I think it<br />
is plain that a person ought to be held accountable for exercising that right.<br />
As the issue <strong>of</strong> culpability in an avoidable mentally disordered state is<br />
analyzed, it may be helpful to keep in mind a specific scenario. Imagine a person<br />
who has schizophrenia, paranoid type, or a person with a condition similar to that<br />
<strong>of</strong> Li or Joubert. As with Joubert (but unlike Li), this person has been diagnosed<br />
by his doctor who has prescribed an anti-psychotic medication to be taken<br />
regularly. The medication is effective and alleviates most symptoms <strong>of</strong> the<br />
disorder, leaving him in a mentally stable phase. The medication produces some<br />
17<br />
18<br />
19<br />
20<br />
21<br />
22<br />
23<br />
Ibid at 20S.<br />
Ibid.<br />
Ibid at 22S.<br />
Ibid at 19S.<br />
Ibid.<br />
See The Mental Health Act , CCSM c M110 s 26.<br />
Ibid at s 27(2).